Fatal liver injury associated with clopidogrel

Fundamental and Clinical Pharmacology

Volumn 24, Issue 4, 2010, Pages 433-435

  Kastalli, Sarrah ^a   El Aïdli, Sihem ^a   Zaïem, Ahmed ^a   Ben Abdallah, Hatem ^b   Daghfous, Riadh ^a  

^a Centre National de Pharmacovigilance   (Tunisia)

^b MILITARY HOSPITAL OF TUNIS   (Tunisia)

Author keywords

adverse effect; clopidogrel; hepatotoxicity

Indexed keywords

CLOPIDOGREL;

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; CORONARY STENT; DRUG WITHDRAWAL; FATALITY; HUMAN; LIVER INJURY; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL;

DRUG-INDUCED LIVER INJURY; FATAL OUTCOME; HUMANS; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; TICLOPIDINE;

EID: 77954421920     PISSN: 07673981     EISSN: 14728206     Source Type: Journal    
DOI: 10.1111/j.1472-8206.2009.00791.x     Document Type: Article

References (9)

1. Bertrand M.E., Rupprecht H.J., Urban P. et al. Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting: the clopidogrel aspirin stent international cooperative study (CLASSICS). Circulation (2000) 102 624 629. (Pubitemid 30640661)
2. Danan G., Benichou Ch. Causality assessment of adverse reactions to drug. A novel method based on the conclusions of International Consensus Meetings: application to drug-induced liver injuries. J. Clin. Epidemiol. (1993) 46 1323 1330. (Pubitemid 23333873)
3. Hollmuller I., Stadlmann S., Graziadei I. et al. Clinico- histopathological characteristics of clopidogrel-induced hepatic injury: case report and review of literature. Eur. J. Gastroenterol. Hepatol. (2006) 18 931 934. (Pubitemid 44034810)
4. Beltrans Robles M., Marquez Saavedra E., Sanchez Munoz D. et al. Hepatotoxicity induced by clopidogrel. J. Hepatol. (2004) 40 560 562.
5. El-Serag H.B., Everhart J.E. Diabetes increases the risk of acute hepatic failure. Gastroenterology (2002) 122 1822 1828. (Pubitemid 34651427)
6. Wang T., Shankar K., Ronis M.J. et al. Mechanisms and outcomes of drug and toxicant-induced liver toxicity in diabetes. Clin. Rev. Toxicol. (2007) 37 413 459. (Pubitemid 47035211)
7. Chalasani N., Fontana R.J., Bonkovsky H.L. et al. Causes, clinical features and outcomes from a prospective study of drug-induced liver injury in United States. Gastroenterology (2008) 135 1924 1934.
8. Richter T., Mürfter Th.E., Heinkele G. et al. Potent mechanism-based inhibition of human CYP2B6 by clopidogrel and ticlopidine. J. Pharmacol. Exp. Ther. (2004) 308 189 197. (Pubitemid 38090717)
9. Simon T., Verstuyft C., Mary-Krause M. et al. Genetic determinants of response to clopidogrel and cardiovascular events. N. Engl. J. Med. (2009) 360 363 375.